MATERIALISE NV (MTLS) Form 6-K — Aug 27, 2026
Materialise NV reported second-quarter 2026 revenue of EUR 70.1 million, up 8.1% year over year, with net profit jumping to EUR 3.3 million (EUR 0.06 per diluted share) from just EUR 0.2 million a year earlier. Growth was led by the Materialise Medical segment, up 12.2% to EUR 36.9 million, while the Manufacturing segment returned to growth on aerospace and defense demand and half-year Adjusted EBIT climbed 71.4% to EUR 6.4 million.
Key figures
- Eps
- EUR 0.06 diluted (Q2 2026) vs EUR 0.00 (Q2 2025); EUR 0.09 diluted (H1 2026) vs EUR (0.01) (H1 2025)
- Revenue
- EUR 70.073 million (Q2 2026); EUR 136.349 million (H1 2026)
- Guidance
- FY2026 revenue reaffirmed at EUR 273-283 million; FY2026 Adjusted EBIT raised to EUR 12-14 million from EUR 10-12 million
- Net Income
- EUR 3.331 million (Q2 2026) vs EUR 0.199 million (Q2 2025); EUR 5.152 million (H1 2026) vs net loss of EUR (0.337) million (H1 2025)
- Total Debt
- EUR 59.521 million gross debt at June 30, 2026 (down from EUR 63.113 million at December 31, 2025)
- Revenue Yoy
- +8.1% Q2 YoY; +3.9% H1 YoY
- Total Assets
- EUR 417.665 million at June 30, 2026
- Cash Position
- EUR 133.735 million cash and equivalents; EUR 74.214 million net cash position at June 30, 2026
- Shares Outstanding
- 58,329 thousand weighted average diluted shares (Q2 2026)
- Fx rate used
- EUR 1.00 = USD 1.1394 (ECB reference rate June 30, 2026)
- Q2 impairment
- EUR 0.689 million non-recurring impairment from Eyewear asset transfer
- Q2 gross margin
- 56.8% vs 58.3% a year earlier
- H1 adjusted ebit
- EUR 6.351 million (+71.4% YoY)
- H1 share buyback
- 1,070,797 shares repurchased for EUR 5.212 million (USD 6.091 million)
- Q2 adjusted ebit
- EUR 3.880 million (+26.9% YoY)
- H1 free cash flow
- EUR 11.368 million
- H1 adjusted ebitda
- EUR 17.642 million (+22.2% YoY)
- Q2 adjusted ebitda
- EUR 9.593 million (+15.7% YoY)
- Q2 revenue medical
- EUR 36.873 million (+12.2% YoY)
- Q2 revenue software
- EUR 9.601 million (-2.7% YoY)
- Shareholders equity
- EUR 256.268 million at June 30, 2026
- H1 operating cash flow
- EUR 15.060 million vs EUR 9.686 million a year earlier
- Q2 revenue manufacturing
- EUR 23.597 million (+6.7% YoY)
AI analysis
Red flags5 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.